Oklahoma 2024 2024 Regular Session

Oklahoma Senate Bill SB1390 Introduced / Bill

Filed 12/15/2023

                     
 
 
Req. No. 2558 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 59th Legislature (2024) 
 
SENATE BILL 1390 	By: McCortney 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to pharmacy benefits managers; 
amending 36 O.S. 2021, Section s 6960, as amended by 
Section 1, Chapter 38, O.S.L. 2022 , 6962, as amended 
by Section 1, Chapter 293, O.S.L. 2023 , 6965, as 
amended by Section 2, Chapter 293, O.S.L. 2023 , 
Section 3, Chapter 38, O.S.L. 2022, as amended by 
Section 3, Chapter 293, O .S.L. 2023, and 6967 (36 
O.S. Supp. 2023, Section s 6960, 6962, 6965, and 
6966.1), which relate to the Pati ent’s Right to 
Pharmacy Choice Act; defining terms; modifying 
definitions; prohibiting certain contract terms from 
restricting document disclosure to certain entities; 
modifying certain compliance provisions ; conforming 
language; construing provisions; providing for rule 
promulgation; establis hing requirements for 
disclosure of protected health information; modifying 
certain fine amount; providing for certain fines an d 
fees; creating the Attorney General ’s Pharmacy 
Benefits Manager Enforcement Revolving Fund; 
establishing fund source; stating p urpose; 
establishing provisions relating to public disclosure 
of certain report and certain information obtained by 
the Attorney General; amending 51 O.S. 2021, Section 
24A.3, as amended by Section 11, Chapter 271, O.S.L. 
2023 (51 O.S. Supp. 2023, Sect ion 24A.3), which 
relates to the Oklahoma Open Records Act; modifying 
definition; amending 59 O.S. 2021, Sections 356.1 and 
358, which relate to pharmacy benefits managers; 
providing for rule promulgation; repealing 36 O.S. 
2021, Section 6966, which relates to the Patient’s 
Right to Pharmacy Choice Commission; updating 
statutory reference; updating statutory language; 
providing for codification; and providing an 
effective date. 
   
 
 
Req. No. 2558 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     36 O.S. 2021, Section 6960, as 
amended by Section 1, Chapter 38, O.S.L. 2022 (36 O.S. Supp. 2023, 
Section 6960), is amended to read as follows: 
Section 6960. For purposes of the Patient ’s Right to Pharmacy 
Choice Act: 
1.  “Covered entity” means a nonprofit hospital or medical 
service organization, insurer, health benefit plan, health 
maintenance organization , health program administered by the s tate 
in the capacity of provid ing health coverage, or an employer, labor 
union, or other entity organized in the state that provides health 
coverage to covered individuals who are employed or reside in the 
state.  This term does not include a health plan that p rovides 
coverage only for accidental injury, specified disease, hospital 
indemnity, disability income, or other limited benefit health 
insurance policies and contracts that do not include prescription 
drug coverage; 
2. “Health insurer” means any corporation, association, benefit 
society, exchange, partnership or individ ual licensed by the 
Oklahoma Insurance Code; 
2. 3.  “Health insurer payor” means a health insurance company, 
health maintenance organization , union, hospital and medical   
 
 
Req. No. 2558 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
services organizatio n or any entity providing or admin istering a 
self-funded health benefit plan; 
3. 4.  “Mail-order pharmacy” means a pharmacy licensed by this 
state that primarily dispenses and delivers covered drugs via common 
carrier; 
4. 5.  “Pharmacy benefits manag er” or “PBM” means a person, 
business, or other entity that performs pharmacy benefits management 
and any other person acting for such person under .  The term shall 
include a person or entity acting on behalf of a PBM in a 
contractual or employm ent relationship in the performance of 
pharmacy benefits management for a managed -care company, nonprofit 
hospital, medical service organization, insurance company, third -
party payor or a health program administered by a department of thi s 
state; 
6.  “Pharmacy benefits management” means a service provided to 
covered entities to facilitate the provision s of prescription drug 
benefits to covered individuals within the state , including, but not 
limited to, negotiating pricing a nd other terms with drug 
manufacturers and provide rs.  Pharmacy benefits management may 
include any or all of the following servi ces: 
a. claims processing, retail network management , and 
payment of claims to pharmacies for prescription drugs 
dispensed to covered individuals ,   
 
 
Req. No. 2558 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
b. clinical formulary developm ent and management 
services, 
c. rebate contracting and administration, 
d. certain patient compliance, therapeutic intervention , 
and generic substitution programs, or 
e. disease management programs; 
5. 7.  “Provider” means a pharmacy, as defined in Section 353.1 
of Title 59 of the Oklahoma Statutes or an agent or representative 
of a pharmacy; 
6. 8.  “Retail pharmacy network ” means retail pharmacy p roviders 
contracted with a PBM in which the pharmacy primari ly fills and 
sells prescriptions via a retail, store front location; 
7. 9.  “Rural service area” means a five-digit ZIP code in which 
the population density is less than one thousa nd (1,000) individuals 
per square mile; 
8. 10.  “Spread pricing” means a prescription drug pricing model 
utilized by a pharmacy b enefits manager in which the PBM charges a 
health benefit plan a contracted pri ce for prescription drugs that 
differs from the amount the PBM directl y or indirectly pays the 
pharmacy or pharmacist for pr oviding pharmacy services; 
9. 11.  “Suburban service area” means a five-digit ZIP code in 
which the population density is between one thousand (1,000) and 
three thousand (3,000) in dividuals per square mile ; and   
 
 
Req. No. 2558 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
10. 12.  “Urban service area” means a five-digit ZIP code in 
which the population density is great er than three thousand (3,000) 
individuals per square mile. 
SECTION 2.     AMENDATORY     36 O.S. 2021, Section 6962, as 
amended by Section 1, Chapter 293, O.S.L. 2023 (36 O.S. Supp. 2023, 
Section 6962), is amended to read as follows: 
Section 6962. A.  The Attorney General shall review and approve 
retail pharmacy network access for all p harmacy benefits managers 
(PBMs) to ensure complian ce with Section 6961 of this title. 
B.  A PBM, or an agent of a PBM, shall not: 
1.  Cause or knowingly permit the use of advertisement, 
promotion, solicitation, representation, propo sal or offer that is 
untrue, deceptive or misleading; 
2.  Charge a pharmacist or phar macy a fee related to the 
adjudication of a claim including without limitation a fee for: 
a. the submission of a claim, 
b. enrollment or participation in a retail pharmacy 
network, or 
c. the development or management of claims processing 
services or claims payment services related to 
participation in a retail pharmacy network; 
3.  Reimburse a pharmacy or pharmacist in the state an amount 
less than the amount that the PBM re imburses a pharmacy owned by or 
under common ownership with a PBM for providing the s ame covered   
 
 
Req. No. 2558 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
services.  The reimbursement amount paid to the pharmacy shall be 
equal to the reimbursement amount calculated on a per-unit basis 
using the same generic product identifier or generic code number 
paid to the PBM-owned or PBM-affiliated pharmacy; 
4.  Deny a provider the opportunity to participate in any 
pharmacy network at preferred participation status if the provider 
is willing to accept the terms and condition s that the PBM has 
established for other providers as a condition of preferred networ k 
participation status; 
5.  Deny, limit or terminate a provider’s contract based on 
employment status of any employee who has an active license to 
dispense, despite probation status, wi th the State Board of 
Pharmacy; 
6. Retroactively deny or re duce reimbursement for a covered 
service claim after returning a paid claim response as part of the 
adjudication of the claim, unless: 
a. the original claim was submitted fraudulentl y, or 
b. to correct errors identified in an audit, so long as 
the audit was conducted in compliance with Sections 
356.2 and 356.3 of Title 59 of the Oklahoma Statutes; 
7.  Fail to make any payment due to a pharmacy or pharmacist for 
covered services properly re ndered in the event a PBM terminates a 
provider from a pharmacy benef its manager network;   
 
 
Req. No. 2558 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
8.  Conduct or practice spread pricing, as defined in Section 1 
of this act Section 6960 of this title , in this state; or 
9. Charge a pharmacist or pharmacy a f ee related to 
participation in a re tail pharmacy network including but not limited 
to the following: 
a. an application fee, 
b. an enrollment or participation fee, 
c. a credentialing or re-credentialing fee, 
d. a change of ownership fee, or 
e. a fee for the development or management of claims 
processing services or claims payment services. 
C.  The prohibitions under this section shall apply to contracts 
between pharmacy benefits managers and providers for participation 
in retail pharmacy networks. 
1.  A PBM contract shall: 
a. not restrict, directly or indirectly, any pharmacy 
that dispenses a presc ription drug from informing, or 
penalize such pharmacy for informing, an individual of 
any differential between the individual’s out-of-
pocket cost or coverage with respect to acquisition of 
the drug and the amount an individual would pay to 
purchase the drug directly, and 
b. ensure that any entity that provides pharmacy benefits 
management services under a contract with any such   
 
 
Req. No. 2558 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
health plan or health insurance cover age does not, 
with respect to such plan or coverage, restrict, 
directly or indirectly, a ph armacy that dispenses a 
prescription drug from inf orming, or penalize such 
pharmacy for informing, a covered individual of any 
differential between the individual ’s out-of-pocket 
cost under the plan or coverage with respect to 
acquisition of the drug and the amount an individual 
would pay for acquisition of the drug without using 
any health plan or health insurance coverage. 
2.  A pharmacy benefits manager ’s contract with a provider shall 
not prohibit, restrict or limit disclosure of information and 
documents to the Attorney General, law enforcement or state and 
federal governmental officials investigating or examining a 
complaint or conducting a review of a pharmacy benefits manager ’s 
compliance with the requirements under the Patient’s Right to 
Pharmacy Choice Act, Pharmacy Audit Integrity A ct, and Section 357 
et seq. of Title 59 of the Okl ahoma Statutes. 
D. A pharmacy benefits manager shall: 
1. Establish and maintain an electronic claim inquiry 
processing system using the National Council for Prescription Drug 
Programs’ current standards to communicate information to pharmacies 
submitting claim inquiries;   
 
 
Req. No. 2558 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  Fully disclose to insurer s, self-funded employers, unions or 
other PBM clients the existence of the re spective aggregate 
prescription drug discounts, rebates rece ived from drug 
manufacturers and pharmacy audit recoupments; 
3.  Provide the Attorney General, insurers, self-funded employer 
plans and unions unrestricted audit rights of and access to the 
respective PBM pharmaceutical manufacturer and provider contracts, 
plan utilization data, plan pricing data, pharmacy utilization data 
and pharmacy pricing data; 
4.  Maintain, for no less than three (3) years, documentation of 
all network development activities including but not limited to 
contract negotiations and any denials to providers to join networks. 
This documentation shall be made available to the Attorney General 
upon request; 
5.  Report to the Attorney General, on a quarterly basis for 
each health insurer pay or, on the following information: 
a. the aggregate amount of rebates received by t he PBM, 
b. the aggregate amount of rebates distributed to the 
appropriate health in surer payor, 
c. the aggregate amount of rebates passed on to the 
enrollees of each healt h insurer payor at the point of 
sale that reduced the applicable deductible, 
copayment, coinsure or other cost sharing amount of 
the enrollee,   
 
 
Req. No. 2558 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
d. the individual and agg regate amount paid by t he health 
insurer payor to the PBM for pharmacy services 
itemized by pharmacy, drug product and service 
provided, and 
e. the individual and aggreg ate amount a PBM paid a 
provider for pharmacy services itemized by pharmacy, 
drug product and service provide d. 
E.  Nothing in the Patient’s Right to Pharmacy Choice Act shall 
prohibit an employer from incentivizing their employees to use an 
employer-owned pharmacy; provided, the employe e may use another in-
network pharmacy of his or her choice. 
F.  Nothing in the Patient’s Right to Pharmacy Choice Act shall 
prohibit the Attorney General from requesting and obtaining detailed 
data, including raw data, in response to the information provided by 
a PBM in the quarterly reports required by this section. 
G.  The Attorney General may promulgate rules to imple ment the 
provisions of the Patient’s Right to Pharmacy Choice A ct. 
SECTION 3.     AMENDATORY     36 O.S. 2021, Section 6965, as 
amended by Section 2, Chapter 2 93, O.S.L. 2023 (36 O.S. Supp. 2023, 
Section 6965), is amended to read as follo ws: 
Section 6965. A.  The Attorney General shall have power and 
authority to examine and investigat e the affairs of every pharmacy 
benefits manager (PBM) engaged in pharmacy benefits manag ement in 
this state in order to determine whet her such entity is in   
 
 
Req. No. 2558 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
compliance with the Patient ’s Right to Pharmacy Choic e Act, Pharmacy 
Audit Integrity Act, and Section 357 et seq. of Title 59 of the 
Oklahoma Statutes. 
B.  All PBM files and records shall be subject to examination by 
the Attorney General or by duly appointed designees.  The Attorney 
General, authorized employees and examiners shall have access to any 
of a PBM’s files and records that may relate to a particular 
complaint under investiga tion or to an inquiry or examin ation by the 
Attorney General. 
C.  Every officer, director, employee or agent of the PB M, upon 
receipt of any inquiry fr om the Attorney General shall, within 
twenty (20) days from the date the inquiry is sent, furnish the 
Attorney General with an adequate response to the i nquiry. 
D.  When making an examination under this sectio n, the Attorney 
General may retain subject matter experts, attorneys, appra isers, 
independent actuaries, independent certified public accountants or 
an accounting firm or individual holding a permit to practice public 
accounting, certified financial examiners o r other professionals and 
specialists as examiners, the cost of w hich shall be borne by the 
PBM that is the subject of the examination. 
E.  1.  Protected health information, or “PHI”, held by a PBM 
shall be provided at the request of the Attor ney General for the 
purpose of conducting investigations into potential violations of 
state laws and regulations related to the PBM.  Disclosure of   
 
 
Req. No. 2558 	Page 12  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
protected health information shall be l imited to the extent 
necessary for the investigation and enforcement of state law. 
2.  All disclosures of protected health information shal l be 
made in compliance with al l applicable federal and sta te privacy 
laws, including the Health Insurance Portability and Accountability 
Act of 1996 (HIPAA), and other relevant laws protecting the privacy 
and confidentiality of health information. 
3.  Any protected health information obtained for an 
investigation shall be handled and maintained per applicable federal 
and state privacy laws and regulations, including HIP AA. 
4.  Unauthorized disclosure of protected health information 
obtained during an investigation is strictly prohibited and subject 
to legal penalties. 
SECTION 4.     AMENDATORY     Section 3, Chapter 38, O.S .L. 
2022, as amended by Section 3, Chapter 293, O.S.L. 2023 (36 O.S. 
Supp. 2023, Section 6966.1), is amended t o read as follows: 
Section 6966.1. A.  The Insurance Commissioner may censure, 
suspend, revoke, or refuse to issue or renew a license of or levy a 
civil penalty against any person licensed under the insurance laws 
of this state for any violation of the Patient’s Right to Pharmacy 
Choice Act, Section 6958 et seq. o f this title. 
B.  1.  If the Attorney General finds, after notice and 
opportunity for hearing, that a pharmacy benefits manager (PBM) 
violated one or more provisions of the Patient’s Right to Pharmacy   
 
 
Req. No. 2558 	Page 13  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Choice Act, the Pharmacy Audit Integrity Act or the provisions of 
Sections 357 through 360 of Title 59 of the Oklahoma Statues, the 
Attorney General may recommend instruct the Insurance Commissioner 
that the PBM be censured, or his or her license may be suspended or 
revoked and a penalty or remedy authorized by this act may be 
imposed.  If the Attorney General makes such recommendation 
instruction, the Commissioner shall take the recommended action 
enforce such action within thirty (30) days. 
2.  In addition to or in lieu of any censure, suspension or 
revocation of a license by the Commissioner, a PBM the Attorney 
General may be subject to levy a civil or administrative fine of not 
less than One Hundred Dollars ($100.00) One Thousand Dollars 
($1,000.00) and not greater than Ten Thousand Dollars ($10,000.00) 
for each violation of the provisions of the Patient’s Right to 
Pharmacy Choice Act, the Pharmacy Audit Integri ty Act or the 
provisions of Sections 357 through 360 of Title 59 of the Oklahoma 
Statues, Statutes. following notice and an opportunity for a hearing 
For purposes of this subsection, each day that a PBM fails to comply 
with an investigation or inquiry may be considered a separate 
violation. 
3.  The Attorney General may order restitution for economic loss 
suffered by pharmacies or patients for violatio ns of this 
subsection.   
 
 
Req. No. 2558 	Page 14  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
C.  Notwithstanding whether the license of a PBM has been 
issued, suspended, revoked, surrendered or lapsed by operation of 
law, the Attorney General is hereby authorized to enforce the 
provisions of the Patient ’s Right to Pharmacy Cho ice Act and impose 
any penalty or remedy authorized under the act against a PBM under 
investigation for or charg ed with a violation of the P atient’s Right 
to Pharmacy Choice Act, the Pharmacy Audit Integrity Act, the 
provisions of Sections 357 through 360 of Title 59 of the Oklahoma 
Statues or any provisi on of the insurance laws of this state. 
D.  Each day that a PBM conducts business in this sta te without 
a license from the Insurance Department shall be deemed a violation 
of the Patient’s Right to Pharmacy Choice Act. 
E.  1.  All hearings conducted by the Office of the Attorney 
General pursuant to this section shall be public and held in 
accordance with the Administrative Procedures Act. 
2.  Hearings shall be held at the office of the Attorney General 
or any other place the Attorney General may deem convenient. 
3. The Attorney General, upon written request from a PBM 
affected by the hearing, shall cause a f ull stenographic record of 
the proceedings to be made by a competent court reporter .  This 
record shall be at the expense of the PBM. 
4.  The ordinary fees and costs of the hearing examiner 
appointed pursuant to Section 319 of this title may be assessed by   
 
 
Req. No. 2558 	Page 15  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
the hearing examiner against the respondent unless the respon dent is 
the prevailing party. 
F.  Any PBM whose license has been censured, suspended, revoked 
or denied renewal or who has had a fine levied against him or her 
shall have the right of appeal from the final order of the Attorney 
General, pursuant to Section 318 et seq. of Title 75 of the Oklahoma 
Statutes. 
G.  If the Attorney General determines, based upon an 
investigation of complaints, that a PBM has engaged in violations of 
the provisions of the Patient’s Right to Pharmacy Choice Act, 
Pharmacy Audit Integrity Act, and Sectio n 357 et seq. of Title 59 of 
the Oklahoma Statutes with such frequency as to indicate a general 
business practice, and that the PBM should be subjected to closer 
supervision with respect to thos e practices, the Attorney General 
may require the PBM to file a report a t any periodic interval the 
Attorney General deems necessary. 
H.  1.  The Attorney General shall have the authority to c ollect 
all fines, penalties, restitution, and interest thereon pursuant to 
the provisions of the Patient’s Right to Pharmacy Choice Act, 
Pharmacy Audit Integrity Act, and the provisions of Section 357 et 
seq. of Title 59 of the Oklahoma Statutes, or any other charge, 
cause of action, prelitigation settlement , or other settlement that 
requires the recovery of money as a result of violations of the 
Patient’s Right to Pharmacy Choice Act.  Funds collected b y the   
 
 
Req. No. 2558 	Page 16  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Attorney General pursuant to the Patient’s Right to Pharmacy Choice 
Act shall be deposited into the Attorney General’s Pharmacy Benefits 
Manager Enforcement Revolving Fund . 
2.  Costs of investigation, litigation, attorney f ees, and other 
expenses incurred shall be re tained by the Office of the Attorney 
General.  Remaining funds shall be distributed to phar macists, 
patients, or other injured parties as determined by the Attorney 
General. 
3.  The Attorney General shall promulgate rules for the 
distribution of fund s pursuant to this subsection. 
SECTION 5.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 6966.2 of Title 36, unless there 
is created a duplication in numbering, reads as follows: 
There is hereby created in the State Tr easury a revolving fund 
for the Office of the Attorney General, to be designat ed the 
“Attorney General’s Pharmacy Benefits Manager Enforcement Revolving 
Fund”.  The fund shall be a continuing fund, not subject to fiscal 
year limitations, and shall consist of any monies designated to the 
fund by law, including those levied for activities related to 
enforcement of the Patient ’s Right to Pharmacy Ch oice Act, the 
Pharmacy Audit Integ rity Act, and the provisions of Sections 3 57 
through 360 of Title 59 of the Okl ahoma Statutes.  All monies 
accruing to the credit of the fund are hereby appropriated and may 
be budgeted and expended by the Attorney General for the purposes   
 
 
Req. No. 2558 	Page 17  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
provided in this section. Expenditures from the fund shall be made 
upon warrants issued by the State Treasurer against claims filed as 
prescribed by law with the Director of the Office of Management and 
Enterprise Services for approval and payment. 
SECTION 6.     AMENDATORY     36 O.S. 2021, Section 6967, is 
amended to read as fol lows: 
Section 6967. A.  Documents, evidence, materials, records, 
reports, complaints or other information in the possession or 
control of the Attorney General or Insurance Department or the Right 
to Pharmacy Choice Commission that are obtained by, created by or 
disclosed to the Attorney General or Insurance Commissioner, 
Pharmacy Choice Commission or any other person in the course of an 
evaluation, examinat ion, investigation or review made pursuant to 
the provisions of the Pat ient’s Right to Pharmacy Choic e Act, the 
Pharmacy Integrity Audit Integrity Act or Sections 357 through 360 
of Title 59 of the Oklahoma Statutes , except as provided in 
subsection C of this section , shall be confidential by law and 
privileged, shall not be subject to open records request, shall not 
be subject to subpoe na and shall not be s ubject to discovery or 
admissible in evidence in any private civil action if obtained from 
the Attorney General, Insurance Commissioner, the Pharmacy Choice 
Commission or any employees or representatives of the Attorney 
General or Insurance Commissioner.   
 
 
Req. No. 2558 	Page 18  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  Nothing in this section shall prevent the discl osure of a 
final order issued against a pharmacy benefits manager by the 
Insurance Commissioner or Pharmacy Choice Commission.  Such orders 
shall be open records. 
C.  Nothing in this section shall prevent t he Attorney General 
from making public, in the form of an examination report, any 
findings from an examination pursuant to Section 6965 of this title.  
It shall be the Attorney General ’s sole discretion to determine 
whether it is in the public’s interest to publish these findings. 
Only the final examination report shall be made public. Any 
documents, evidence, materials, rec ords, reports, complaints, or 
other information in possession or control of the Attorney General 
obtained through the examination shall be confidential by law and 
privileged, shall not be subject to the Oklahoma Open Records Act, 
shall not be subject to subpoena, and shall not be subject to 
discovery or admissible evidence in any pri vate civil action if 
obtained from the Attorney Gene ral. 
D. In the course of any hearing made pursuant to the prov isions 
of the Patient’s Right to Pharmacy Choice Act, the Phar macy 
Integrity Audit Act or Sections 357 through 360 of Title 59 of the 
Oklahoma Statutes, nothing in this section shall be construed to 
prevent the Insurance Commissioner or any employees or 
representatives of the Insurance Comm issioner from presenting   
 
 
Req. No. 2558 	Page 19  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
admissible documents, evidence, ma terials, records, reports or 
complaints to the adjudicating authority. 
SECTION 7.     AMENDATORY     51 O.S. 2021, Section 24A.3, as 
amended by Section 11, Chapter 271, O.S.L. 2023 (51 O.S. Supp. 2023, 
Section 24A.3), is amended to read as follows: 
Section 24A.3. As used in the Oklahoma Open Records A ct: 
1.  “Record” means all documents including, but not limited to, 
any book, paper, photograph, microfilm, data files created by or 
used with computer software, computer tape, disk, record, sound 
recording, film recording, video record o r other material regardless 
of physical form or characteristic, created by, received by, under 
the authority of, or coming into the custody, control o r possession 
of public officials, public bodies or their rep resentatives in 
connection with the transaction of public busin ess, the expenditure 
of public funds or the administering of public property .  Record 
does not mean: 
a. computer software, 
b. nongovernment personal effe cts, 
c. unless public disclosure is req uired by other laws or 
regulations, vehicle mov ement records of the Oklahoma 
Transportation Authority obtained in connection with 
the Authority’s electronic toll collection system, 
d. personal financial information, credit r eports or 
other financial data ob tained by or submitted to a   
 
 
Req. No. 2558 	Page 20  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
public body for the pu rpose of evaluating credit 
worthiness, obtaining a license, permit or for the 
purpose of becoming qualified to contract with a 
public body, 
e. any digital audio/video recordings of the toll 
collection and safeguarding activities of the Oklahoma 
Transportation Authority, 
f. any personal information provided by a guest at any 
facility owned or opera ted by the Oklahoma Tourism and 
Recreation Department to obtain any service at t he 
facility or by a purchaser of a product sold by or 
through the Oklahoma Touris m and Recreation 
Department, 
g. a Department of Defense Form 214 (DD Form 214) filed 
with a county clerk including any DD Form 214 filed 
before July 1, 2002, 
h. except as provided for in Section 2 -110 of Title 47 of 
the Oklahoma Statutes : 
(1) any record in connection with a Motor Ve hicle 
Report issued by the Department of Public Safety, 
as prescribed in Section 6-117 of Title 47 of the 
Oklahoma Statutes, or 
(2) personal information within driver records, as 
defined by the Driver’s Privacy Protection Ac t,   
 
 
Req. No. 2558 	Page 21  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
18 United States Code, Sections 2721 through 
2725, which are stored and maintained by the 
Department of Public Safety, 
i. any portion of any document or information prov ided to 
an agency or entity of the state or a political 
subdivision to obtain li censure under the laws of this 
state or a political subdivision that contains an 
applicant’s personal address, personal phone number, 
personal electronic mail address or other contact 
information.  Provided, however, lists of persons 
licensed, the existenc e of a license of a person, or a 
business or commercial address, or other business or 
commercial information disclosable under state law 
submitted with an application for licen sure shall be 
public record, or 
j. an investigative file obtained during an inv estigation 
conducted by the State Department of Health under this 
act the Oklahoma Open Records Act , or 
k. information deemed confidential pursuant to the 
provisions of the Patient’s Right to Pharmacy Choice 
Act; 
2.  “Public body” shall include, but not be lim ited to, any 
office, department, board, bureau, commission , agency, trusteeship, 
authority, council, committee, trust or any entity creat ed by a   
 
 
Req. No. 2558 	Page 22  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
trust, county, city, village, town, township, district, s chool 
district, fair board, cour t, executive office, advis ory group, task 
force, study group or any subdivision thereof, supported in whole or 
in part by public funds or entrusted with the ex penditure of public 
funds or administering or operating public property , and all 
committees, or subcommittees thereof .  Except for the records 
required by Section 24A.4 of this title, public body does not mean 
judges, justices, the Council on Judicial Complaints, the 
Legislature or legislators.  Public body shall not include an 
organization that is exempt from federal inc ome tax under Section 
501(c)(3) of the Internal Revenue Code of 1986, as amended, and 
whose sole beneficiary is a college or university, or an affiliated 
entity of the college or uni versity, that is a member of The 
Oklahoma State System of Higher Education . Such organization shall 
not receive direct appropriation s from the Oklahoma Legislature.  
The following persons shall not be eligible to serve as a voting 
member of the governing board of the organization: 
a. a member, officer, or employee of the Oklaho ma State 
Regents for Higher Education, 
b. a member of the board of regents or other governing 
board of the college or university that is the sole 
beneficiary of the organization, or 
c. an officer or employee of the college or university 
that is the sole beneficiary of the organization;   
 
 
Req. No. 2558 	Page 23  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  “Public office” means the physical location where public 
bodies conduct business or keep reco rds; 
4.  “Public official” means any official or emplo yee of any 
public body as defined herein; and 
5.  “Law enforcement agency ” means any public body charged with 
enforcing state or local criminal laws and initiating crimi nal 
prosecutions including, but n ot limited to, police departments, 
county sheriffs, the Department of Public Sa fety, the Oklahoma State 
Bureau of Narcotics and Dangerous Drugs Control, the Alcoholic 
Beverage Laws Enforc ement Commission, and the Oklahoma State Bureau 
of Investigation. 
SECTION 8.     AMENDATORY     59 O.S. 2 021, Section 356.1, i s 
amended to read as follows: 
Section 356.1.  A.  For purposes of the Pharmacy Audit Integrity 
Act, “pharmacy benefits manager ” or “PBM” means a person, business, 
or other entity that performs pharmacy benefits management.  The 
term includes a person or entity acting for a PBM in a contractual 
or employment relationship in the performance of pharmacy benefits 
management for a managed care company, nonprofit hospital, medical 
service organization, insurance company, third -party payor, or a 
health program administered by a department of this state. 
B.  The purpose of the Pharmacy Audit Integrity Act is to 
establish minimum and uniform standar ds and criteria for the audit 
of pharmacy records by or on behalf of certain entities.   
 
 
Req. No. 2558 	Page 24  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
C.  The Pharmacy Audit Integrity Act shall apply to any audit of 
the records of a pharm acy conducted by a managed care company, 
nonprofit hospital, medical service organization, insurance company, 
third-party payor, pharmacy benefits manager, a health program 
administered by a department of this state, or any entity that 
represents these companies, groups, or departments. 
D.  The Attorney General may promulgate rules to i mplement the 
provisions of the Pharmacy Audit Integrity Act. 
SECTION 9.     AMENDATORY     59 O.S. 2021, Section 358, is 
amended to read as follows: 
Section 358. A.  In order to provide pharmacy benefits 
management or any of the services included under the definit ion of 
pharmacy benefits management in this state, a pharmac y benefits 
manager or any entity acting as one in a contractual or employment 
relationship for a covered entity shall first obtain a license from 
the Oklahoma Insurance Department, and the Departm ent may charge a 
fee for such licensure. 
B.  The Department shall establish, by regulation, licensure 
procedures, required disclosures for p harmacy benefits managers 
(PBMs) and other rules as may be necess ary for carrying out and 
enforcing the provisions of this act the Oklahoma Pharmacy Act .  The 
licensure procedures shall, a t a minimum, include the completion of 
an application form that shall include t he name and address of an   
 
 
Req. No. 2558 	Page 25  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
agent for service of process, the payment of a requisite fee, and 
evidence of the procurement of a suret y bond. 
C.  The Department may subpoena wi tnesses and information.  Its 
compliance officers may take and copy records for investigative use 
and prosecutions.  Nothing in this subse ction shall limit the Office 
of the Attorney General from using its investi gative demand 
authority to investigate and prose cute violations of the law. 
D.  The Department may suspend, revoke or refuse to issue or 
renew a license for noncompliance with any of the provisions hereby 
established or with the rules promulgated by the D epartment; for 
conduct likely to mislead, de ceive or defraud the public or the 
Department; for unfair or deceptive business practices or for 
nonpayment of a renewal fee or fine .  The Department may also levy 
administrative fines for each count of which a PBM has been 
convicted in a Department hearing. 
E. The Attorney General may promulgate rules to implement the 
provisions of Sections 357 et seq. of this title. 
SECTION 10.     REPEALER     36 O.S. 2021, Section 6966, is 
hereby repealed. 
SECTION 11.  This act shall become eff ective November 1, 2024. 
 
59-2-2558 RD 12/15/2023 1:57:11 PM